Status: current, Primitive. Date: 30-Sep 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2084701000168117 | Naropin 0.5% (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2084711000168119 | Naropin 0.5% | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Naropin 0.5% | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Naropin 0.5% (ropivacaine hydrochloride 50 mg / 10 mL) injection, 5 x 10 mL ampoules (containered trade product pack) | has TP | True | Naropin 0.5% | Inferred relationship | Some | |
| Naropin 0.5% 50 mg/10 mL injection, 5 x 10 mL ampoules | has TP | True | Naropin 0.5% | Inferred relationship | Some | |
| Naropin 0.5% 100 mg/20 mL injection, 5 x 20 mL ampoules | has TP | True | Naropin 0.5% | Inferred relationship | Some | |
| Naropin 0.5% 100 mg/20 mL injection, 5 x 20 mL ampoules | has TP | True | Naropin 0.5% | Inferred relationship | Some | |
| Naropin 0.5% 100 mg/20 mL injection, 20 mL ampoule | Is a | True | Naropin 0.5% | Inferred relationship | Some | |
| Naropin 0.5% 50 mg/10 mL injection, 10 mL ampoule | Is a | True | Naropin 0.5% | Inferred relationship | Some |
Reference Sets
FHIR